S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 421 to 480 of 539

Issue Date	Title / Author(s) / Citation	File
2017-05	Risk stratification and prognostic nomogram for postrecurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue HPB, Vol.19 No.5, pp.421-428	DOI
2017-06	Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication Park, Seongyeol; Ha, Seunggyun; Kwon, Hyun Woo; Kim, Woo Hyoung; Kim, Tae-Yong; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.6, pp.899-904	DOI
2017-06	Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial Chu, Michael P.; Hecht, J. Randolph; Slamon, Dennis; Wainberg, Zev A.; Bang, Yung-Jue; Hoff, Paulo M.; Sobrero, Alberto; Qin, Shukui; Afenjar, Karen; Houe, Vincent; King, Karen; Koski, Sheryl; Mulder, Karen; Hiller, Julie Price; Scarfe, Andrew; Spratlin, Jennifer; Huang, Yingjie J.; Khan-Wasti, Saba; Chua, Neil; Sawyer, Michael B. JAMA oncology, Vol.3 No.6, pp.767-773	DOI
2017-06	A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification Van Cutsem, E.; Bang, Y. -J.; Mansoor, W.; Petty, R. D.; Chao, Y.; Cunningham, D.; Ferry, D. R.; Smith, N. R.; Frewer, P.; Ratnayake, J.; Stockman, P. K.; Kilgour, E.; Landers, D. Annals of Oncology, Vol.28 No.6, pp.1316-1324	DOI
2017-06	Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Molecular Cancer Therapeutics, Vol.16 No.6, pp.1145-1154	DOI
2017-07	Findings of a 1303 Korean whole-exome sequencing study Kwak, Soo Heon; Chae, Jeesoo; Choi, Seongmin; Kim, Min Jung; Choi, Murim; Chae, Jong-Hee; Cho, Eun-hae; Hwang, Tai Ju; Jang, Se Song; Kim, Jong-Il; Park, Kyong Soo; Bang, Yung-Jue Experimental and Molecular Medicine, Vol.49, p. e356	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-07	Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea Carter, Gebra Cuyun; Kaltenboeck, Anna; Ivanova, Jasmina; Liepa, Astra M.; Roman, Alexandra San; Koh, Maria; Rajan, Narayan; Cheng, Rebecca; Birnbaum, Howard G.; Kim, Jong Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.578-587	DOI
2017-08	Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer Jo, Jaemin; Kwon, Hyun Woo; Park, Seongyeol; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.8, pp.1255-1261	DOI
2017-08	A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer Michael, Michael; Bang, Yung-Jue; Park, Young Suk; Kang, Yoon-Koo; Kim, Tae Min; Hamid, Oday; Thornton, Donald; Tate, Sonya C.; Raddad, Eyas; Tie, Jeanne Targeted Oncology, Vol.12 No.4, pp.463-474	DOI
2017-08	Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study Ott, Patrick A.; Bang, Yung-Jue; Berton-Rigaud, Dominique; Elez, Elena; Pishvaian, Michael J.; Rugo, Hope S.; Puzanov, Igor; Mehnert, Janice M.; Aung, Kyaw L.; Lopez, Juanita; Carrigan, Marion; Saraf, Sanatan; Chen, Mei; Soria, Jean-Charles Journal of Clinical Oncology, Vol.35 No.22, pp.2535-2541	DOI
2017-08	HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Shah, Manish A.; Xu, Rui-hua; Bang, Yung-Jue; Hoff, Paulo M.; Liu, Tianshu; Herraez-Baranda, Luis A.; Xia, Fan; Garg, Amit; Shing, Mona; Tabernero, Josep Journal of Clinical Oncology, Vol.35 No.22, pp.2558-2567	DOI
2017-09	A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer Reynolds, Kerry Lynn; Bedard, Philippe L.; Lee, Se-Hoon; Lin, Chia-Chi; Tabernero, Josep; Alsina, Maria; Cohen, Ezra; Baselga, Jose; Blumenschein, George, Jr.; Graham, Donna M.; Garrido-Laguna, Ignacio; Juric, Dejan; Sharma, Sunil; Salgia, Ravi; Seroutou, Abdelkader; Tian, Xianbin; Fernandez, Rose; Morozov, Alex; Sheng, Qing; Ramkumar, Thiruvamoor; Zubel, Angela; Bang, Yung-Jue BMC Cancer, Vol.17, p. 646	view file DOI
2017-09	Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution Kim, Byoung Hyuck; Chie, Eui Kyu; Kim, Kyubo; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue; Ha, Sung W. Oncotarget, Vol.8 No.44, pp.78076-78085	DOI
2017-09	Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment Kwon, J.; Kim, K.; Chie, E. K.; Kim, B. H.; Jang, J. -Y.; Kim, S. W.; Oh, D. -Y.; Bang, Y. -J. European Journal of Surgical Oncology, Vol.43 No.9, pp.1690-1696	DOI
2017-10	A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors Mateo, Joaquin; Ganji, Gopinath; Lemech, Charlotte; Burris, Howard A.; Han, Sae-Won; Swales, Karen; Decordova, Shaun; DeYoung, M. Phillip; Smith, Deborah A.; Kalyana-Sundaram, Shanker; Wu, Jiuhua; Motwani, Monica; Kumar, Rakesh; Tolson, Jerry M.; Rha, Sun Young; Chung, Hyun Cheol; Eder, Joseph P.; Sharma, Sunil; Bang, Yung-Jue; Infante, Jeffrey R.; Yan, Li; de Bono, Johann S.; Arkenau, Hendrik-Tobias Clinical Cancer Research, Vol.23 No.19, pp.5981-5992	DOI
2017-10	Efficacy of sequential ipilimumab monotherapy versus best supportive care for unresectable locally advanced/metastatic gastric or gastroesophageal junction cancer Bang, Yung-Jue; Cho, Jae Yong; Kim, Yeul Hong; Kim, Jin Won; Di Bartolomeo, Maria; Ajani, Jaffer A.; Yamaguchi, Kensei; Balogh, Agnes; Sanchez, Teresa; Moehler, Markus Clinical Cancer Research, Vol.23 No.19, pp.5671-5678	DOI
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI
2017-10	Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79441-79452	DOI
2017-10	Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer Shitara, Kohei; Kim, Tae Min; Yokota, Tomoya; Goto, Masahiro; Satoh, Taroh; Ahn, Jin-Hee; Kim, Hyo Song; Assadourian, Sylvie; Gomez, Corinne; Harnois, Marzia; Hamauchi, Satoshi; Kudo, Toshihiro; Doi, Toshihido; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79546-79555	DOI
2017-12	Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial Bang, Yung-Jue; Xu, Rui-Hua; Chin, Keisho; Lee, Keun-Wook; Park, Se Hoon; Rha, Sun Young; Shen, Lin; Qin, Shukui; Xu, Nong; Im, Seock-Ah; Locker, Gershon; Rowe, Phil; Shi, Xiaojin; Hodgson, Darren; Liu, Yu-Zhen; Boku, Narikazu The Lancet Oncology, Vol.18 No.12, pp.1637-1651	DOI
2017-12	Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer Jin, Ling; Jin, Mei-hua; Nam, Ah-Rong; Park, Ji-Eun; Bang, Ju-Hee; Oh, Do Yeun; Bang, Yung Jue Cancer Letters, Vol.411, pp.162-170	DOI
2017-12	Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy Kim, Yi-Jun; Koh, Hyeon Kang; Chie, Eui Kyu; Oh, Do-Youn; Bang, Yung-Jue; Nam, Eun Mi; Kim, Kyubo International Journal of Clinical Oncology, Vol.22 No.6, pp.1069-1075	DOI
2018-01	Safety and antitumor activity of pembrolizumab in advanced programmed death Ligand 1-positive endometrial cancer: Results from the KEYNOTE-028 study Ott, Patrick A.; Bang, Yung-Jue; Berton-Rigaud, Dominique; Elez, Elena; Pishvaian, Michael J.; Rugo, Hope S.; Puzanov, Igor; Mehnert, Janice M.; Aung, Kyaw L.; Lopez, Juanita; Carrigan, Marion; Saraf, Sanatan; Chen, Mei; Soria, Jean-Charles Obstetrical and Gynecological Survey, Vol.73 No.1, pp.26-27	DOI
2018-01	S-1-induced lacrimal drainage obstruction and its association with ingredients/metabolites of S-1 in tears and plasma: A prospective multi-institutional study Kim, Namju; Kim, Jin Won; Baek, Je-Hyun; Kim, Jin-Soo; Choung, Ho-Kyung; Kim, Tae-Yong; Lee, Kyung-Hun; Bang, Yung-Jue; Khwarg, Sang In; Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho; Chung, Jae-Yong; Ahn, Soyeon; Lee, Keun-Wook Cancer Research and Treatment, Vol.50 No.1, pp.30-39	DOI
2018-02	Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors Lee, Keun-Wook; Lee, Dae Ho; Kang, Jin Hyoung; Park, Joon Oh; Kim, Se Hyun; Hong, Yong Sang; Kim, Seung Tae; Oh, Do-Youn; Bang, Yung-Jue Oncologist, Vol.23 No.2, pp.155-e17	DOI
2018-02	Use of olaparib in patients with advanced gastric cancer Bang, Yung-Jue The Lancet Oncology, Vol.19 No.2, pp.E76-E76	DOI
2018-03	Long-term trastuzumab (Herceptin (R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer Mueller, Volkmar; Clemens, Michael; Jassem, Jacek; Al-Sakaff, Nedal; Auclair, Petra; Nuesch, Eveline; Holloway, Debbie; Shing, Mona; Bang, Yung-Jue BMC Cancer, Vol.18, p. 295	view file DOI
2018-03	Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 Tahara, Makoto; Muro, Kei; Hasegawa, Yasuhisa; Chung, Hyun Cheol; Lin, Chia-Chi; Keam, Bhumsuk; Takahashi, Kenichi; Cheng, Jonathan D.; Bang, Yung-Jue Cancer Science, Vol.109 No.3, pp.771-776	DOI
2018-04	TAK-264 (MLN0264) in previously treated Asian patients with advanced gastrointestinal carcinoma expressing guanylyl cyclase C: Results from an open-label, non-randomized phase 1 study Bang, Yung-Jue; Takano, Toshimi; Lin, Chia-Chi; Fasanmade, Adedigbo; Yang, Huyuan; Danaee, Hadi; Asato, Takayuki; Kalebic, Thea; Wang, Hui; Doi, Toshihiko Cancer Research and Treatment, Vol.50 No.2, pp.398-404	DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2018-05	Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives Taieb, Julien; Moehler, Markus; Boku, Narikazu; Ajani, Jaffer A.; Ruiz, Eduardo Yanez; Ryu, Min-Hee; Guenther, Silke; Chand, Vikram; Bang, Yung-Jue Cancer Treatment Reviews, Vol.66, pp.104-113	DOI
2018-05	Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial Fuchs, Charles S.; Doi, Toshihiko; Jang, Raymond W.; Muro, Kei; Satoh, Taroh; Machado, Manuela; Sun, Weijing; Jalal, Shadia I.; Shah, Manish A.; Metges, Jean-Phillipe; Garrido, Marcelo; Golan, Talia; Mandala, Mario; Wainberg, Zev A.; Catenacci, Daniel V.; Ohtsu, Atsushi; Shitara, Kohei; Geva, Ravit; Bleeker, Jonathan; Ko, Andrew H.; Ku, Geoffrey; Philip, Philip; Enzinger, Peter C.; Bang, Yung-Jue; Levitan, Diane; Wang, Jiangdian; Rosales, Minori; Dalal, Rita P.; Yoon, Harry H. JAMA oncology, Vol.4 No.5, p. e180013	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2018-07	Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): A randomised, open-label, controlled, phase 3 trial Shitara, Kohei; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Goekkurt, Eray; Mansoor, Wasat; McDermott, Raymond S.; Shacham-Shmueli, Einat; Chen, Xinqun; Mayo, Carlos; Kang, S. Peter; Ohtsu, Atsushi; Fuchs, Charles S. The Lancet, Vol.392 No.10142, pp.123-133	DOI
2018-10	Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: Primary analysis of JAVELIN Gastric 300 Bang, Y. -J.; Ruiz, E. Yanez; Van Cutsem, E.; Lee, K. -W.; Wyrwicz, L.; Schenker, M.; Alsina, M.; Ryu, M. -H.; Chung, H. -C.; Evesque, L.; Al-Batran, S. -E.; Park, S. H.; Lichinitser, M.; Boku, N.; Moehler, M. H.; Hong, J.; Xiong, H.; Hallwachs, R.; Conti, I.; Taieb, J. Annals of Oncology, Vol.29 No.10, pp.2052-2060	DOI
2019-02	T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028 Ott, Patrick A.; Bang, Yung-Jue; Piha-Paul, Sarina A.; Razak, Albiruni R. Abdul; Bennouna, Jaafar; Soria, Jean-Charles; Rugo, Hope S.; Cohen, Roger B.; O'Neil, Bert H.; Mehnert, Janice M.; Lopez, Juanita; Doi, Toshihiko; van Brummelen, Emilie M. J.; Cristescu, Razvan; Yang, Ping; Emancipator, Kenneth; Stein, Karen; Ayers, Mark; Joe, Andrew K.; Lunceford, Jared K. Journal of Clinical Oncology, Vol.37 No.4, pp.318-327	DOI
2019-02	A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer Bang, Y. -J.; Kang, Y. -K.; Ng, M.; Chung, H. C.; Wainberg, Z. A.; Gendreau, S.; Chan, W. Y.; Xu, N.; Maslyar, D.; Meng, R.; Chau, I; Ajani, J. A. European Journal of Cancer, Vol.108, pp.17-24	DOI
2019-02	SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer van den Boom, Hector G.; Abu-Hanna, Ameen; ter Veer, Emil; van Kleef, Jessy Joy; Lordick, Florian; Stahl, Michael; Ajani, Jaffer A.; Guimbaud, Rosine; Park, Se Hoon; Dutton, Susan J.; Bang, Yung-Jue; Boku, Narikazu; Mohammad, Nadia Haj; Sprangers, Mirjam A. G.; Verhoeven, Rob H. A.; Zwinderman, Aeilko H.; van Oijen, Martijn G. H.; van Laarhoven, Hanneke W. M. Cancers, Vol.11 No.2, p. 187	DOI
2019-02	Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design Moehler, Markus; Ryu, Min-Hee; Dvorkin, Mikhail; Lee, Keun-Wook; Coskun, Hasan S.; Wong, Rachel; Chung, Hyun C.; Poltoratsky, Artem; Tsuji, Akihito; Yen, Chia Jui; Muntean, Alina S.; Le Sourd, Samuel; Vaccaro, Gina M.; Overton, Lindsay; Boku, Narikazu; Wainberg, Zev A.; Patel, Manish; Sharma, Maitreyi; Xiong, Huiling; Conti, Ilaria; Taieb, Julien; Bang, Yung-Jue Future Oncology, Vol.15 No.6, pp.567-577	DOI
2019-03	KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Ohtsu, Atsushi; Tabernero, Josep; Ilson, David H.; Hyung, Woo Jin; Strong, Vivian E.; Goetze, Thorsten Oliver; Yoshikawa, Takaki; Tang, Laura H.; Hwang, Peggy May Tan; Webb, Nancy; Adelberg, David; Shitara, Kohei Future Oncology, Vol.15 No.9, pp.943-952	DOI
2019-04	Pan-PIM kinase inhibitor AZD1208 suppresses tumor growth and synergistically interacts with AKT inhibition in gastric cancer cells Lee, Miso; Lee, Kyung-Hun; Min, Ahrum; Kim, Jeongeun; Kim, Seongyeong; Jang, Hyemin; Lim, Jee Min; Kim, So Hyeon; Ha, Dong-Hyeon; Jeong, Won Jae; Suh, Koung Jin; Yang, Yae-Won; Kim, Tae Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.51 No.2, pp.451-463	DOI
2019-04	Dynamics of soluble programmed death-ligand 1 (SPDL1) during chemotherapy and its prognostic implications in cancer patients: Biomarker development in immuno-oncology Ha, Hyerim; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji-Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.51 No.2, pp.832-840	DOI
2019-05	Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer Kim, Hee Sung; Hwang, In Gyu; Min, Hye Young; Bang, Yung-Jue; Kim, Woo Ho Oncology Letters, Vol.17 No.5, pp.4383-4392	DOI
2019-06	Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea Im, Seock-Ah; Lee, Dae-Won; Kang, Ryungwoo; Kim, Jee Hyun; Kim, Dong-Wan; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Chinese Clinical Oncology, Vol.8 No.3, p. 27	view file DOI
2019-06	Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors Jung, Kyung Hae; LoRusso, Patricia; Burris, Howard; Gordon, Michael; Bang, Yung-Jue; Hellmann, Matthew D.; Cervantes, Andres; Ochoa de Olza, Maria; Marabelle, Aurelien; Hodi, Stephen; Ahn, Myung-Ju; Emens, Leisha A.; Barlesi, Fabrice; Hamid, Omid; Calvo, Emiliano; McDermott, David; Soliman, Hatem; Rhee, Ina; Lin, Ray; Pourmohamad, Tony; Suchomel, Julia; Tsuhako, Amy; Morrissey, Kari; Mahrus, Sami; Morley, Roland; Pirzkall, Andrea; Davis, S. Lindsey Clinical Cancer Research, Vol.25 No.11, pp.3220-3228	DOI
2019-07	Jab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.886-900	DOI
2019-07	Therapeutic targeting of the DNA damage response using an ATR inhibitor in biliary tract cancer Nam, Ah-Rong; Jin, Mei Hua; Park, Ji Eun; Bang, Ju-Hee; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.1167-1179	DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI
2019-07	Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors Hellmann, M. D.; Kim, T. -W.; Lee, C. B.; Goh, B-C; Miller, W. H., Jr.; Oh, D. -Y.; Jamal, R.; Chee, C. -E.; Chow, L. Q. M.; Gainor, J. F.; Desai, J.; Solomon, B. J.; Das Thakur, M.; Pitcher, B.; Foster, P.; Hernandez, G.; Wongchenko, M. J.; Cha, E.; Bang, Y. -J.; Siu, L. L.; Bendell, J. Annals of Oncology, Vol.30 No.7, pp.1134-1142	DOI
2019-07	Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 Shaw, Alice Tsang; Riely, Gregory J.; Bang, Yung-Jue; Kim, Dong-Wan; Camidge, David Ross; Solomon, Benjamin J.; Varella-Garcia, Marileila; Iafrate, Anthony John; Shapiro, Geoffrey I.; Usari, Tiziana; Wang, S. C.; Wilner, Keith. D.; Clark, Jeffrey W.; Ou, Sai Hong Ignatius Annals of Oncology, Vol.30 No.7, pp.1121-1126	DOI
2019-08	A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Keun-Wook; Han, Sae-Won; Kim, Jin Won; Shin, Jung-Won; Jo, Seong-Jin; Won, Jonghwa; Hahn, Seokyung; Lee, Howard; Kim, Woo Ho; Bang, Yung-Jue Oncologist, Vol.24 No.8, pp.1037-e636-+	DOI
2019-08	Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: Phase Ib study Kim, Jin Won; Lee, Kyung-Hun; Kim, Ji-Won; Suh, Koung Jin; Nam, Ah-Rong; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn British Journal of Cancer, Vol.121 No.4, pp.332-339	DOI
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2019-11	Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis Park, Changhee; Keam, Bhumsuk; Yoon, Soon Ho; Ock, Chan-Young; Choi, Sun Mi; Kim, Miso; Park, Young Sik; Kim, Tae Min; Oh, Do-Youn; Kim, Dong-Wan; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Esmo Open, Vol.4 No.6, p. e000575	DOI
2019-11	A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer Kim, Tae-Yong; Han, Hye Sook; Lee, Keun-Wook; Zang, Dae Young; Rha, Sun Young; Park, Young lee; Kim, Jin-Soo; Lee, Kyung-Hun; Park, Se Hoon; Song, Eun-Kee; Jung, Soo-A; Lee, NaMi; Kim, Yeul Hong; Cho, Jae Yong; Bang, Yung-Jue Gastric Cancer, Vol.22 No.6, pp.1206-1214	DOI
2019-12	Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Scientific Reports, Vol.9 No.1, p. 11131	DOI
2020-01	Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study Yoo, Shin Hye; Kang, Seo Young; Cheon, Gi Jeong; Oh, Do-Youn; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.61 No.1, pp.33-39	DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI

1 5 6 7 8 9